{"id":"https://openalex.org/W2171204232","doi":"https://doi.org/10.1177/1087054708316250","title":"Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study","display_name":"Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study","alternate_titles":[],"publication_year":2008,"publication_date":"2008-04-30","ids":{"openalex":"https://openalex.org/W2171204232","doi":"https://doi.org/10.1177/1087054708316250","mag":"2171204232","pmid":"https://pubmed.ncbi.nlm.nih.gov/18448861"},"language":"en","primary_location":{"id":"doi:10.1177/1087054708316250","doi":"https://doi.org/10.1177/1087054708316250","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1087054708316250","pdf_url":null,"source":{"id":"https://openalex.org/S4019948","display_name":"Journal of Attention Disorders","issn_l":"1087-0547","issn":["1087-0547","1557-1246"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Attention Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2171204232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010701317","display_name":"Lenard A. Adler","orcid":"https://orcid.org/0000-0002-9812-8234","observed_orcids":["https://orcid.org/0000-0002-9812-8234"]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Lenard A. Adler","raw_affiliation_strings":["New York University and New York VA Harbor Healthcare System,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University and New York VA Harbor Healthcare System,","institution_ids":["https://openalex.org/I2800015068","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069963123","display_name":"Thomas J. Spencer","orcid":"https://orcid.org/0000-0001-5661-3293","observed_orcids":["https://orcid.org/0000-0001-5661-3293"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas J. Spencer","raw_affiliation_strings":["Massachusetts General Hospital, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026562442","display_name":"David Wynne Williams","orcid":"https://orcid.org/0000-0002-7351-5131","observed_orcids":["https://orcid.org/0000-0002-7351-5131"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David W. Williams","raw_affiliation_strings":["Lilly Research Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089114657","display_name":"Rodney J. Moore","orcid":"https://orcid.org/0009-0003-9801-0660","observed_orcids":["https://orcid.org/0009-0003-9801-0660"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rodney J. Moore","raw_affiliation_strings":["Lilly Research Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064619641","display_name":"David Michelson","orcid":"https://orcid.org/0009-0005-5804-1424","observed_orcids":["https://orcid.org/0009-0005-5804-1424"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Michelson","raw_affiliation_strings":["Lilly Research Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010701317"],"corresponding_institution_ids":["https://openalex.org/I2800015068","https://openalex.org/I57206974"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":null,"fwci":6.4452,"has_fulltext":false,"cited_by_count":95,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96739039,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"3","first_page":"248","last_page":"253"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/adult-adhd","display_name":"adult ADHD","score":0.8500000238418579},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.781000018119812},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.7369999885559082},{"id":"https://openalex.org/keywords/adhd-symptom-reduction","display_name":"ADHD symptom reduction","score":0.6570000052452087},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.4580000042915344},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7910000085830688},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9499902725219727},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7841310501098633},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.6218053698539734},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5906987190246582},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5835957527160645},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5607154369354248},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.5318460464477539},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39890095591545105},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3659061789512634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35807332396507263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31244826316833496},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.11443158984184265},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.08714550733566284}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D039721","descriptor_name":"Diagnostic and Statistical Manual of Mental Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1087054708316250","doi":"https://doi.org/10.1177/1087054708316250","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1087054708316250","pdf_url":null,"source":{"id":"https://openalex.org/S4019948","display_name":"Journal of Attention Disorders","issn_l":"1087-0547","issn":["1087-0547","1557-1246"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Attention Disorders","raw_type":"journal-article"},{"id":"pmid:18448861","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18448861","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of attention disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1787873135","https://openalex.org/W1995416536","https://openalex.org/W2016483680","https://openalex.org/W2035623112","https://openalex.org/W2053295943","https://openalex.org/W2061378977","https://openalex.org/W2079590493","https://openalex.org/W2114613490","https://openalex.org/W2121528518","https://openalex.org/W2122518346","https://openalex.org/W2123980944","https://openalex.org/W2140513029","https://openalex.org/W2143384791","https://openalex.org/W2159011576","https://openalex.org/W2160070901","https://openalex.org/W2400578408","https://openalex.org/W3090293687","https://openalex.org/W3196369884","https://openalex.org/W4245708356"],"related_works":["https://openalex.org/W2068396310","https://openalex.org/W2035623112","https://openalex.org/W2325084394","https://openalex.org/W1970457084","https://openalex.org/W1535576495","https://openalex.org/W2115800923","https://openalex.org/W2129129238","https://openalex.org/W1522095004","https://openalex.org/W1492384425","https://openalex.org/W2050880665"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Previously,":[1],"data":[2],"from":[3,26,36],"97":[4],"weeks":[5,57],"of":[6,10,21,30,39,58,125,132,143,148],"open-label":[7,47,134],"atomoxetine":[8,144],"treatment":[9,147],"adults":[11],"with":[12],"attention-deficit/hyperactivity":[13],"disorder":[14],"(ADHD)":[15],"were":[16,34,83,101],"reported.":[17],"This":[18],"final":[19],"report":[20],"that":[22],"study":[23,38,135],"presents":[24],"results":[25],"over":[27],"4":[28],"years":[29],"treatment.":[31,59,97],"METHOD:":[32],"Results":[33,131],"derived":[35],"the":[37,46,50,64,104,109,137,146],"384":[40],"patients":[41,43],"(125":[42],"remaining":[44],"in":[45],"trial":[48],"since":[49],"interim":[51],"report),":[52],"receiving":[53],"up":[54],"to":[55],"221":[56],"Primary":[60],"efficacy":[61,106],"measure":[62],"was":[63],"Conners'":[65],"Adult":[66],"ADHD":[67,75,88],"Rating":[68],"Scale-Investigator":[69],"Rated:":[70],"Screening":[71],"Version":[72],"(CAARS-Inv:SV)":[73],"Total":[74,87,113],"Symptom":[76,89],"score.":[77],"Adverse":[78,121],"events":[79,122],"and":[80,141],"vital":[81],"signs":[82],"assessed.":[84],"RESULTS:":[85],"CAARS-Inv:SV":[86],"scores":[90],"decreased":[91],"30.2%":[92],"(p":[93,118],"<":[94,119],".001)":[95],"during":[96],"Similar,":[98],"significant":[99],"decreases":[100],"noted":[102],"for":[103,145],"secondary":[105],"measures,":[107],"including":[108],"Sheehan":[110],"Disability":[111],"Scale":[112],"score,":[114],"which":[115],"improved":[116],"25.3%":[117],".001).":[120],"consisted":[123],"primarily":[124],"pharmacologically":[126],"(noradrenergic)":[127],"expected":[128],"effects.":[129],"CONCLUSIONS:":[130],"this":[133],"support":[136],"long-term":[138],"efficacy,":[139],"safety,":[140],"tolerability":[142],"adult":[149],"ADHD.":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2171204232","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
